Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | 15 | 0 | 1 | 0 | 44,80 € | 46,51 € | 3,81 % |
| Henry Schein Inc. | 15 | 1 | 3 | 0 | 63,84 € | 76,08 € | 19,17 % |
| iRhythm Technologies Inc | 15 | 1 | 5 | 1 | 61,50 € | 114,25 € | 85,77 % |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | 12,50 € | 20,33 € | 62,67 % |
| Verastem Inc. | 14 | 0 | 3 | 0 | 2,26 € | 16,16 € | 615,10 % |
| Universal Health Services B | 14 | 6 | 1 | 0 | 216,00 € | 150,90 € | -30,14 % |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 2 | 0 | 18,32 € | 26,64 € | 45,45 % |
| Twist Bioscience Corp | 13 | 1 | 2 | 1 | 39,08 € | 41,80 € | 6,96 % |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | 0,74 € | 13,86 € | 1772,36 % |
| Staar Surgical Co. | 13 | 1 | 1 | 0 | 29,30 € | 47,59 € | 62,44 % |
| Incyte Corp. | 13 | 2 | 0 | 0 | 59,42 € | 77,67 € | 30,72 % |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | 19,10 € | 78,70 € | 312,04 % |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | 178,90 € | 247,61 € | 38,41 % |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | 435,30 € | 554,23 € | 27,32 % |
| AnaptysBio Inc | 12 | 1 | 3 | 0 | 34,40 € | 48,09 € | 39,79 % |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | 71,46 € | 84,81 € | 18,68 % |
| LivaNova plc | 12 | 0 | 0 | 0 | 46,20 € | 66,49 € | 43,92 % |
| QIAGEN NV | 12 | 0 | 1 | 0 | 40,47 € | 47,52 € | 17,42 % |
| Amedisys Inc. | 11 | 0 | 0 | 0 | 87,00 € | 92,26 € | 6,05 % |
| Teleflex Inc. | 11 | 0 | 2 | 0 | 218,00 € | 245,97 € | 12,83 % |
| Pro-Dex Inc. | 11 | 0 | 1 | 0 | 20,40 € | - | - |
| Affimed N.V. | 11 | 6 | 0 | 0 | 0,55 € | 7,92 € | 1331,34 % |
| Adverum Biotechnologies Inc. | 11 | 0 | 2 | 0 | 1,38 € | 23,35 € | 1591,67 % |
| Heron Therapeutics Inc. | 11 | 1 | 1 | 0 | 1,78 € | 4,63 € | 160,02 % |
| Sangamo Therapeutics Inc. | 11 | 15 | 1 | 0 | 0,76 € | 3,64 € | 377,35 % |